In Vitro Diagnostics Analyzers Global Market Analysis - A $16.3 Billion Market by 2028, Growing at a CAGR of 4.7 %

News provided by

Dec 28, 2023, 11:45 ET

DUBLIN, Dec. 28, 2023 /PRNewswire/ -- The "In Vitro Diagnostics (IVD) Analyzers: Global Market" report has been added to ResearchAndMarkets.com's offering.

The global market for IVD analyzers was valued at $12.2 billion in 2022, and is projected to reach $16.3 billion by the end of 2028 at a CAGR of 4.7 % during the forecast period of 2023 to 2028. The increasing elderly population, growing incidence of chronic diseases, widening use of diagnostics for prevention and monitoring, and growing adoption of PoC testing are driving market growth.

Based on analyzer type, the market is categorized into immunoassay analyzers, clinical chemistry analyzers, hematology and hemostasis analyzers, molecular diagnostic analyzers and PoC analyzers. The molecular analyzers segment, which held the third largest market share in 2022, is expected to show the highest CAGR, at 6.0%, during the forecast period. This segment's share is attributed to the growing incidence of cancer and cancer-related diseases.

The market is also segmented into semi-automated and fully automated analyzers. The semi-automated segment accounted for 67.2% of the market in 2022. The fully automated segment is expected to grow at a higher CAGR of 6.4% during the forecast period, due to an increasing focus on automated and modulator laboratories. Its market share is expected to increase to 35.5% in 2028, up from 32.8% in 2022.

Based ontherapeutic area, the market for IVD analyzers is segmented into infectious diseases, diabetes, cardiology, oncology, nephrology and others. Infectious diseases accounted for 46.25 of the market in 2022 and this segment is expected to grow at a CAGR of 4.3% during the forecast period. The diabetes segment is a distant second, with 9.7% of the market in 2022, and it is expected to grow at a CAGR of 5.8% during the forecast period.

In this report, the end users of IVD analyzers consist of diagnostic laboratories, hospitals and clinics, research institutions, and others. Diagnostic labs accounted for 52.3% of the market share in 2022, and the segment is expected to grow at a CAGR of 5.0% during the forecast period. The increasing number of large laboratory networks with advanced instruments is driving the growth of this segment.

The current report highlights the current and future market potential of in vitro diagnostics analyzers along with an analysis of the drivers, restraints, challenges, and emerging trends in the market.

The Report Includes

39 data tables and 34 additional tables
An analysis of the global market for in vitro diagnostics (IVD) analyzers
Analyses of global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Estimate of the actual market size and revenue forecast, and corresponding market share analysis by test type, level of automation, application, end user and region
Facts and figures pertaining to the market growth drivers, opportunities and restraints, innovations and prospects, technologies, regulatory scenarios, and COVID-19's impact on the IVD industry
Discussion of sustainability trends and factors in the IVD analyzer market, with emphasis on consumer attitudes, companies' ESG scores, future of ESG, case studies and the ESG practices of leading companies
Overview of the emerging new technologies and patents in the market
Analysis of the major vendors in the market as well as the competitive landscape, including company market shares, financials, M&A deals and venture fundings
Profiles of the leading market players, including Siemens Healthineers, Abbott Laboratories, F. Hoffmann-La Roche, Bio-Rad Laboratories, Danaher Corp., and Thermo Fisher Scientific

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Chapter 4 Market Dynamics

Chapter 5 Market Breakdown by Analyzer Type

Global Market for IVD Analyzers
Market Analysis
Immunoassay Analyzers
Market Size and Forecast
Clinical Chemistry Analyzers
Hematology and Hemostasis Analyzers
Molecular Diagnostic Analyzers
Point-of-Care Analyzers
Other Analyzers

Chapter 6 Market Breakdown by Level of Automation

Semi-Automated Analyzers
Fully Automated Analyzers

Chapter 7 Market Breakdown by Therapeutic Area

Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology

Chapter 8 Market Breakdown by End User

Diagnostic Labs
Hospitals and Clinics
Research Institutions
Other Users

Chapter 9 Market Breakdown by Region

Chapter 10 ESG Development

Sustainability in the IVD Analyzer Industry: An ESG Perspective
Key ESG Issues
Environmental Performance of IVD Companies
Social Performance of Key IVD Analyzers Companies
Governance Performance of IVD Analyzer Companies
Consumer Attitudes toward ESG in the IVD Analyzer Market
Case Study
Concluding Remarks

Chapter 11 Emerging Technologies and Developments

Technologies in the Market
Integration of AI and Machine Learning
Digital Morphology
Connected PoC Devices
Microfluidics and Miniaturization

Chapter 12 Regulatory Scenario

Chapter 13 M&A Analysis

Chapter 14 Competitive Landscape

Chapter 15 Company Profiles

Abbott Diagnostics
Becton, Dickinson And Co.
Biomerieux
Bio-Rad Laboratories
Danaher
Ekf Diagnostics Holdings
F. Hoffmann-La Roche
Quidelortho
Shenzhen Mindray Bio-Medical Electronics
Siemens Healthineers
Sysmex Corp.
Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/r/7d782w

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo:https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets